Wednesday, June 22, 2011

Lamotrigin Alpharma




Lamotrigin Alpharma may be available in the countries listed below.


Ingredient matches for Lamotrigin Alpharma



Lamotrigine

Lamotrigine is reported as an ingredient of Lamotrigin Alpharma in the following countries:


  • Finland

International Drug Name Search

Sunday, June 19, 2011

Darvon-N


Pronunciation: proe-POX-ih-feen
Generic Name: Propoxyphene
Brand Name: Darvon and Darvon-N

Darvon-N should not be used by people who are suicidal or who easily become addicted to medicines, alcohol, or other substances. Do not take more of Darvon-N than the dose your doctor prescribed. Taking excessive doses of Darvon-N by itself, with other medicines, or with alcohol may cause serious side effects and could be fatal. Limit the amount of alcohol you drink while you are taking Darvon-N. Tell your doctor if you have a history of any substance abuse, mood or mental disorders, suicidal thoughts or attempts, or if you take any medicines that cause drowsiness such as tranquilizers, sleep medicines, muscle relaxers, or antidepressants.





Darvon-N is used for:

Relieving mild to moderate pain.


Darvon-N is a narcotic analgesic. It works in the brain to decrease pain.


Do NOT use Darvon-N if:


  • you are allergic to any ingredient in Darvon-N

  • you have severe diarrhea caused by antibiotic use (pseudomembranous colitis) or poisoning

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Darvon-N:


Some medical conditions may interact with Darvon-N. Tell your health care provider if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have prostate problems, liver problems (eg, hepatitis), or kidney problems

  • if you have a history of drug abuse or dependence or depression or have ever seriously considered suicide

  • if you have had a head injury, increased pressure in your brain, growths in your brain, or seizures

  • if you have inflammatory bowel problems or ulcers, urinary problems, or you have had abdominal surgery

  • if you have lung or breathing problems (eg, asthma), thyroid problems, heart problems, or certain blood problems (porphyria)

Some MEDICINES MAY INTERACT with Darvon-N. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Anticoagulants (eg, warfarin) because side effects, including an increased risk of bleeding, may be increased by Darvon-N

  • Carbamazepine because the risk of severe side effects and toxicity, including nausea, vomiting, loss of coordination, and involuntary eye movements, may occur

  • Antidepressant medicines (eg, amitriptyline, phenelzine), anticonvulsants (eg, phenobarbital, phenytoin), barbiturate anesthetics (eg, thiopental), cimetidine, HIV protease inhibitors (eg, ritonavir), and terfenadine because side effects may be increased by Darvon-N

  • Naltrexone because the effectiveness of Darvon-N may be decreased

  • Sodium oxybate (GHB) because side effects, including increased risk of sleep duration and drowsiness leading to unresponsiveness and coma, may be increased by Darvon-N

This may not be a complete list of all interactions that may occur. Ask your health care provider if Darvon-N may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Darvon-N:


Use Darvon-N as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Darvon-N may be taken with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • Darvon-N comes with an additional patient leaflet. Read it carefully and reread it each time you get Darvon-N refilled.

  • Do not take more than your prescribed dose or take Darvon-N for longer than prescribed by your health care provider.

  • If you miss a dose of Darvon-N and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Darvon-N.



Important safety information:


  • Darvon-N may cause drowsiness or dizziness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Darvon-N. Using Darvon-N alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Use of alcohol with Darvon-N may cause serious side effects. Limit your intake of alcohol while taking Darvon-N. If you drink alcohol every day, do not take Darvon-N without talking to your health care provider first. The combination of Darvon-N and alcohol may cause liver damage.

  • Make sure your health care provider knows if you are taking tranquilizers, sleep aids, antidepressant medicines, antihistamines, or any other medicines that may make you sleepy. The combination of these products with Darvon-N may lead to serious side effects, including death.

  • If you experience dizziness, drowsiness, nausea, or vomiting, it may help to lie down.

  • Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Darvon-N.

  • Darvon-N may be habit-forming. Do not take more than the dose prescribed by your doctor or take Darvon-N for a longer period of time than prescribed by your doctor.

  • Use Darvon-N with caution in the ELDERLY because they may be more sensitive to its effects.

  • Use Darvon-N with extreme caution in CHILDREN. Use of Darvon-N is not recommended in CHILDREN younger than 12 years of age. Safety and effectiveness in this age group have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Darvon-N during pregnancy. Darvon-N is excreted in breast milk. If you are or will be breast-feeding while you are using Darvon-N, check with your doctor or pharmacist to discuss the risks to your baby.

When used for long periods of time or at high doses, Darvon-N may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Darvon-N stops working well. Do not take more than prescribed.


Darvon-N can cause DEPENDENCE if taken in higher doses than recommended by your health care provider or over a long period of time. Take Darvon-N exactly as prescribed by your health care provider. If you suddenly stop taking Darvon-N, you may experience WITHDRAWAL symptoms including anxiety; diarrhea; fever, runny nose, or sneezing; goosebumps and abnormal skin sensations; nausea; pain; rapid heartbeat; rigid muscles; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; trouble sleeping; and vomiting.



Possible side effects of Darvon-N:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; dizziness; drowsiness; lightheadedness; nausea; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); anxiety; cold or clammy skin; confusion; excessive sweating; hallucinations; loss of appetite; loss of consciousness; mental or mood changes; seizures; severe drowsiness or dizziness; severe or persistent stomach pain; vision changes; weakness; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Darvon-N side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include anxiety; confusion; dilated pupils; irregular heartbeat; muscle pain; severe drowsiness or dizziness; slow or difficult breathing; weakness.


Proper storage of Darvon-N:

Store Darvon-N at room temperature, between 68 and 77 degrees F (20 and 25 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Keep Darvon-N out of the reach of children and away from pets.


General information:


  • If you have any questions about Darvon-N, please talk with your doctor, pharmacist, or other health care provider.

  • Darvon-N is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Darvon-N. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Darvon-N resources


  • Darvon-N Side Effects (in more detail)
  • Darvon-N Use in Pregnancy & Breastfeeding
  • Drug Images
  • Darvon-N Drug Interactions
  • Darvon-N Support Group
  • 1 Review for Darvon-N - Add your own review/rating


  • Darvon-N Prescribing Information (FDA)

  • Darvon-N Advanced Consumer (Micromedex) - Includes Dosage Information

  • Darvon-N Concise Consumer Information (Cerner Multum)

  • Propoxyphene Professional Patient Advice (Wolters Kluwer)

  • Darvon Prescribing Information (FDA)

  • Propoxyphene Hydrochloride Monograph (AHFS DI)



Compare Darvon-N with other medications


  • Pain

Monday, June 13, 2011

Berminbe




Berminbe may be available in the countries listed below.


Ingredient matches for Berminbe



Thiamine

Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Berminbe in the following countries:


  • Japan

International Drug Name Search

Sunday, June 5, 2011

Oxecta


Oxecta is a brand name of oxycodone, approved by the FDA in the following formulation(s):


OXECTA (oxycodone hydrochloride - tablet; oral)



  • Manufacturer: KING PHARMS R AND D

    Approval date: June 17, 2011

    Strength(s): 5MG, 7.5MG

Has a generic version of Oxecta been approved?


No. There is currently no therapeutically equivalent version of Oxecta available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Oxecta. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Methods and compositions for deterring abuse of opioid containing dosage forms
    Patent 7,201,920
    Issued: April 10, 2007
    Inventor(s): Kumar; Vijai & Dixon; David & Tewari; Divya & Wadgaonkar; Dilip B.
    Assignee(s): Acura Pharmaceuticals, Inc.
    This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Patent expiration dates:

    • March 16, 2025
      ✓ 
      Drug product




  • Methods and compositions for deterring abuse of opioid containing dosage forms
    Patent 7,510,726
    Issued: March 31, 2009
    Inventor(s): Kumar; Vijai & Dixon; David & Tewari; Divya & Wadgaonkar; Dilip B.
    Assignee(s): Acura Pharmaceuticals, Inc.
    This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Patent expiration dates:

    • November 26, 2023
      ✓ 
      Drug product




  • Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof
    Patent 7,981,439
    Issued: July 19, 2011
    Inventor(s): Kumar; Vijai & Dixon; David & Tewari; Divya & Wadgaonkar; Dilip B.
    Assignee(s): Acura Pharmaceuticals, Inc.
    This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
    Patent expiration dates:

    • November 26, 2023
      ✓ 
      Drug product



See also...

  • Oxecta Consumer Information (Drugs.com)
  • Oxecta Advanced Consumer Information (Micromedex)
  • Oxycodone Consumer Information (Drugs.com)
  • Oxycodone Consumer Information (Wolters Kluwer)
  • Oxycodone Concentrate Consumer Information (Wolters Kluwer)
  • Oxycodone Solution Consumer Information (Wolters Kluwer)
  • Oxycodone Sustained-Release Tablets Consumer Information (Wolters Kluwer)
  • Oxycodone Consumer Information (Cerner Multum)
  • Oxy IR Advanced Consumer Information (Micromedex)
  • Oxycontin CR Advanced Consumer Information (Micromedex)
  • Oxycodone Advanced Consumer Information (Micromedex)
  • Oxycodone AHFS DI Monographs (ASHP)
  • Oxycodone Hydrochloride AHFS DI Monographs (ASHP)

Contac Cold & Sore Throat, Non Drowsy




Contac Cold & Sore Throat, Non Drowsy may be available in the countries listed below.


Ingredient matches for Contac Cold & Sore Throat, Non Drowsy



Paracetamol

Paracetamol is reported as an ingredient of Contac Cold & Sore Throat, Non Drowsy in the following countries:


  • Canada

Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Contac Cold & Sore Throat, Non Drowsy in the following countries:


  • Canada

International Drug Name Search

Losartan Farmindustria




Losartan Farmindustria may be available in the countries listed below.


Ingredient matches for Losartan Farmindustria



Losartan

Losartan is reported as an ingredient of Losartan Farmindustria in the following countries:


  • Peru

International Drug Name Search

Saturday, June 4, 2011

Burneze




Burneze may be available in the countries listed below.


Ingredient matches for Burneze



Benzocaine

Benzocaine is reported as an ingredient of Burneze in the following countries:


  • Malta

International Drug Name Search